MATTHEW BASSETT: Open Payments
NPI 1679909873 · SLIDELL, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,271 in 62 payments from 19 companies in 2025. Trend: 2023 $1,413 · 2024 $1,348 · 2025 $1,271
Food & beverage: $1,271
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 17 | $299 |
| AstraZeneca Pharmaceuticals LP | 6 | $264 |
| Novo Nordisk Inc | 7 | $119 |
| PFIZER INC. | 5 | $94 |
| Lilly USA, LLC | 5 | $81 |
| ABBVIE INC. | 4 | $70 |
| Exact Sciences Corporation | 3 | $60 |
| Dexcom, Inc. | 2 | $43 |
| Saluda Medical Americas, Inc. | 1 | $42 |
| Amneal Pharmaceuticals LLC | 2 | $34 |
Products named: BREZTRI, TRELEGY ELLIPTA, SHINGRIX, JARDIANCE, Cologuard Collection Kit, Wegovy, Dexcom G6 Transmitter, Evoke.
Industry payments across LA — which companies pay providers there.
